Annual Accounts Receivable
$142.00 M
+$47.18 M+49.76%
December 31, 2024
Summary
- As of March 12, 2025, AXSM annual accounts receivable is $142.00 million, with the most recent change of +$47.18 million (+49.76%) on December 31, 2024.
- During the last 3 years, AXSM annual accounts receivable has risen by +$142.00 million (+100.00%).
- AXSM annual accounts receivable is now at all-time high.
Performance
AXSM Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$142.00 M
+$17.91 M+14.43%
December 31, 2024
Summary
- As of March 12, 2025, AXSM quarterly accounts receivable is $142.00 million, with the most recent change of +$17.91 million (+14.43%) on December 31, 2024.
- Over the past year, AXSM quarterly accounts receivable has increased by +$47.18 million (+49.76%).
- AXSM quarterly accounts receivable is now at all-time high.
Performance
AXSM Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
AXSM Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +49.8% | +49.8% |
| 3 y3 years | +100.0% | +49.8% |
| 5 y5 years | - | - |
AXSM Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | at high | -100.0% |
| 5 y | 5-year | at high | -100.0% | at high | -100.0% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Axsome Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $142.00 M(+49.8%) | $142.00 M(+14.4%) |
| Sep 2024 | - | $124.10 M(+3.1%) |
| Jun 2024 | - | $120.34 M(+18.6%) |
| Mar 2024 | - | $101.43 M(+7.0%) |
| Dec 2023 | $94.82 M | $94.82 M(+20.9%) |
| Sep 2023 | - | $78.42 M(+16.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $67.41 M(+50.5%) |
| Mar 2023 | - | $44.79 M(+18.8%) |
| Dec 2022 | $37.70 M(>+9900.0%) | $37.70 M(+85.7%) |
| Sep 2022 | - | $20.30 M(+25.6%) |
| Jun 2022 | - | $16.17 M(>+9900.0%) |
| Dec 2021 | $0.00 | $0.00 |
FAQ
- What is Axsome Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Axsome Therapeutics?
- What is Axsome Therapeutics annual accounts receivable year-on-year change?
- What is Axsome Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly accounts receivable year-on-year change?
What is Axsome Therapeutics annual accounts receivable?
The current annual accounts receivable of AXSM is $142.00 M
What is the all time high annual accounts receivable for Axsome Therapeutics?
Axsome Therapeutics all-time high annual accounts receivable is $142.00 M
What is Axsome Therapeutics annual accounts receivable year-on-year change?
Over the past year, AXSM annual accounts receivable has changed by +$47.18 M (+49.76%)
What is Axsome Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of AXSM is $142.00 M
What is the all time high quarterly accounts receivable for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly accounts receivable is $142.00 M
What is Axsome Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, AXSM quarterly accounts receivable has changed by +$47.18 M (+49.76%)